- Home
- LGVN vs STAI Comparison
LGVN vs STAI Comparison
Compare LGVN & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- STAI
- Stock Information
- Founded
- LGVN 2014
- STAI 2011
- Country
- LGVN United States
- STAI United States
- Employees
- LGVN N/A
- STAI N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- STAI
- Sector
- LGVN Health Care
- STAI
- Exchange
- LGVN Nasdaq
- STAI Nasdaq
- Market Cap
- LGVN 23.4M
- STAI 24.6M
- IPO Year
- LGVN 2021
- STAI N/A
- Fundamental
- Price
- LGVN $1.23
- STAI $0.78
- Analyst Decision
- LGVN Strong Buy
- STAI
- Analyst Count
- LGVN 3
- STAI 0
- Target Price
- LGVN $8.67
- STAI N/A
- AVG Volume (30 Days)
- LGVN 132.9K
- STAI 958.6K
- Earning Date
- LGVN 05-08-2025
- STAI 01-01-0001
- Dividend Yield
- LGVN N/A
- STAI N/A
- EPS Growth
- LGVN N/A
- STAI N/A
- EPS
- LGVN N/A
- STAI N/A
- Revenue
- LGVN $2,225,000.00
- STAI $542,166.00
- Revenue This Year
- LGVN N/A
- STAI N/A
- Revenue Next Year
- LGVN $24.82
- STAI N/A
- P/E Ratio
- LGVN N/A
- STAI N/A
- Revenue Growth
- LGVN 127.50
- STAI N/A
- 52 Week Low
- LGVN $0.77
- STAI $0.68
- 52 Week High
- LGVN $6.40
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- LGVN 39.93
- STAI N/A
- Support Level
- LGVN $1.25
- STAI N/A
- Resistance Level
- LGVN $1.37
- STAI N/A
- Average True Range (ATR)
- LGVN 0.09
- STAI 0.00
- MACD
- LGVN -0.01
- STAI 0.00
- Stochastic Oscillator
- LGVN 30.00
- STAI 0.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.